Physician profile
Mark L Miles
NPI 1174579379
$3,825.89
in general payments reported to CMS, 2019-2025
40 companies · $78.98 in 2025
The $78.98 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $421 · 2021: $957 · 2022: $918 · 2023: $827 · 2024: $141 · 2025: $78.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.52 | 2020-2023 | |
| Pfizer INC. | $383.03 | 2019-2023 | |
| Esperion Therapeutics, INC. | $344.19 | 2020-2021 | |
| Abbott Laboratories | $276.86 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $254.51 | 2019-2024 | Shingrix |
| Astellas Pharma US INC | $199.72 | 2019-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $198.63 | 2019-2022 | |
| Amgen INC. | $192.31 | 2019-2023 | Otezla, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $168.51 | 2020-2022 | |
| Exact Sciences Corporation | $135.20 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $132.90 | 2021-2023 | |
| Amarin Pharma, INC. | $113.62 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.69 | 2021-2023 | Xifaxan |
| Baxter Healthcare | $84.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $82.89 | 2023 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $80.78 | 2021-2022 | |
| Novo Nordisk INC | $61.88 | 2019-2023 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $58.23 | 2023-2024 | Gemtesa |
| Takeda Pharmaceuticals U.S.A., INC. | $57.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.26 | 2022 | |
| Inari Medical, INC. | $46.33 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Antares Pharma, INC. | $37.46 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $30.16 | 2020 | |
| Medtronic, INC. | $28.51 | 2021-2022 | |
| Seqirus USA INC | $26.88 | 2022 | |
| Lilly USA, LLC | $26.53 | 2022 | |
| Dexcom, INC. | $24.03 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $22.68 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $20.58 | 2023 | |
| Philips North America LLC | $19.80 | 2020 | |
| Halozyme INC | $18.80 | 2023 | |
| Incyte Corporation | $17.73 | 2023 | Opzelura |
| Corium, LLC | $15.70 | 2023 | Azstarys |
| Adlon Therapeutics L.P. | $15.52 | 2020 | |
| Supernus Pharmaceuticals, INC. | $15.16 | 2020 | Xyosted |
| Idorsia Pharmaceuticals US INC | $13.62 | 2023 | Quviviq |
| Intuity Medical INC | $13.56 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Evofem Biosciences, INC. | $12.93 | 2021 | |
| Almatica Pharma LLC | $11.97 | 2021 | |
| Acadia Pharmaceuticals INC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.